Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

Last updated: July 21, 2025
Sponsor: University of Massachusetts, Amherst
Overall Status: Completed

Phase

N/A

Condition

Mild Cognitive Impairment

Memory Loss

Dementia

Treatment

Neuro-World

Clinical Study ID

NCT04920123
2585
  • Ages > 55
  • All Genders

Study Summary

This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Seventeen points or greater and smaller than twenty-six points on the MontrealCognitive Assessment (MoCA)

  • Fifty-five years old and above

  • Minimal technological literacy (i.e. ability to use a tablet independently)

  • Having a computer for online videoconferencing-based communication (necessary foronline cognitive assessments)

Exclusion

Exclusion Criteria:

  • Confounding neurological and psychiatric disorders

  • History of traumatic brain injury

  • Clinically known hearing or vision impairment

  • Severe upper-limb motor impairments that could impact the use of mobile devices

  • Clinical presentations suggestive of dementia with Lewy bodies, progressivesupranuclear palsy, multiple system atrophy, or vascular parkinsonism

  • Diagnosis of dementia

  • Major depression

  • Any significant upper-limb impairment that could affect tablet use

  • Participation in any other therapist-supervised cognitive training

Study Design

Total Participants: 19
Treatment Group(s): 1
Primary Treatment: Neuro-World
Phase:
Study Start date:
February 17, 2022
Estimated Completion Date:
March 31, 2025

Study Description

This study will be a cross-over randomized controlled trial.

Fifty participants will be enrolled and randomly assigned to group A or group B.

Group A will self-administer Neuro-World cognitive training games for 30 minutes a day, twice a week for 12 weeks in the home setting (i.e., intervention period). For the following 12 weeks, the participants will not engage in any therapist-supervised cognitive therapies (i.e., no-intervention period).

Group B will not engage in any therapist-supervised cognitive therapies (i.e., no-intervention period). For the following 12 weeks, the participants will self-administer Neuro-World cognitive training games for 30 minutes a day, twice a week in the home setting (i.e., intervention period).

All the participants in both groups will receive phone calls twice a week to 1) provide feedback on their adherence to Neuro-World cognitive training (during the intervention period) and 2) learn any significant changes in the level of their daily activities (during the no-intervention period and the intervention period).

Connect with a study center

  • University of Massachusetts, Amherst

    Amherst, Massachusetts 01003
    United States

    Site Not Available

  • The State University of New Jersey, Rutgers

    Newark, New Jersey 07102
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.